Function of the immune system in liver cirrhosis

被引:10
作者
Bahr, MJ [1 ]
Manns, MP [1 ]
机构
[1] Hannover Med Sch, Gastroenterol & Hepatol Abt, D-30623 Hannover, Germany
来源
ZEITSCHRIFT FUR GASTROENTEROLOGIE | 2001年 / 39卷 / 08期
关键词
immune system; liver cirrhosis; infections; macrophages; RES; neutrophile granulocytes; natural killer cells; lymphocytes; opsonines; vaccination;
D O I
10.1055/s-2001-16696
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Malfunction of the immune system at different levels is typical for patients with liver cirrhosis. Both non-specific as well as antigen-specific functions may be compromised. The best studied and clinically most important problem is the diminished clearance capacity of the reticulo-endothelial system in liver cirrhosis. This transfers into a significantly higher rate of bacterial infections associated with a poorer prognosis in these patients. The clinical relevance of concomitant immune disorders like neutrophil dysfunction is less clear. An impaired activation of natural killer cells (NK) and lymphokine-actvated killer cells (LAK) may have a role in the development of hepatocellular carcinoma but additional studies are needed. Clinically important is a moderately reduced efficacy of standard immunization protocols, which can be overcome by an increased dose in most vaccines.
引用
收藏
页码:601 / 607
页数:7
相关论文
共 76 条
[1]   NEUTROPHIL ADHERENCE IN CHRONIC LIVER-DISEASE AND FULMINANT HEPATIC-FAILURE [J].
ALTIN, M ;
RAJKOVIC, IA ;
HUGHES, RD ;
WILLIAMS, R .
GUT, 1983, 24 (08) :746-750
[2]  
BEUTLER BA, 1985, J IMMUNOL, V135, P3972
[3]   CLINICAL-SIGNIFICANCE OF THE EVALUATION OF HEPATIC RETICULOENDOTHELIAL REMOVAL CAPACITY IN PATIENTS WITH CIRRHOSIS [J].
BOLOGNESI, M ;
MERKEL, C ;
BIANCO, S ;
ANGELI, P ;
SACERDOTI, D ;
AMODIO, P ;
GATTA, A .
HEPATOLOGY, 1994, 19 (03) :628-634
[4]   A PROSPECTIVE-STUDY OF BACTERIAL-INFECTIONS IN PATIENTS WITH CIRRHOSIS [J].
CALY, WR ;
STRAUSS, E .
JOURNAL OF HEPATOLOGY, 1993, 18 (03) :353-358
[5]   Intestinal permeability in liver cirrhosis: relationship with severe septic complications [J].
Campillo, B ;
Pernet, P ;
Bories, PN ;
Richardet, JP ;
Devanlay, M ;
Aussel, C .
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 1999, 11 (07) :755-759
[6]   PLASMA-CLEARANCE, ORGAN DISTRIBUTION AND TARGET-CELLS OF INTERLEUKIN-6 HEPATOCYTE-STIMULATING FACTOR IN THE RAT [J].
CASTELL, JV ;
GEIGER, T ;
GROSS, V ;
ANDUS, T ;
WALTER, E ;
HIRANO, T ;
KISHIMOTO, T ;
HEINRICH, PC .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1988, 177 (02) :357-361
[7]   NATURAL-KILLER-CELL ACTIVITY IN PATIENTS WITH LIVER-CIRRHOSIS RELATIVE TO SEVERITY OF LIVER-DAMAGE [J].
CHUANG, WL ;
LIU, HW ;
CHANG, WY ;
CHEN, SC ;
HSIEH, MY ;
WANG, LY .
DIGESTIVE DISEASES AND SCIENCES, 1991, 36 (03) :299-302
[8]   Antibody response to hepatitis B virus vaccination in individuals with hepatitis C virus infection [J].
De Maria, N ;
Idilman, R ;
Colantoni, A ;
Harig, JM ;
Van Thiel, DH .
HEPATOLOGY, 2000, 32 (02) :444-444
[9]   DEFECTIVE CHEMOTAXIS ASSOCIATED WITH A SERUM INHIBITOR IN CIRRHOTIC PATIENTS [J].
DEMEO, AN ;
ANDERSEN, BR .
NEW ENGLAND JOURNAL OF MEDICINE, 1972, 286 (14) :735-&
[10]  
Deschênes M, 1999, AM J GASTROENTEROL, V94, P2193, DOI 10.1016/S0002-9270(99)00349-4